Close Menu

NEW YORK – Ginkgo Bioworks today announced a $290 Series E financing round from new and prior investors.

New investors include funds and accounts advised by T. Rowe Price Associates. All major existing investors participated in the round, Ginkgo said. The firm said it would use the funding to grow its cell programming platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.